Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 4
2022 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Facts and Hopes in Immunotherapy of Soft-Tissue Sarcomas.
Martín-Broto J, Moura DS, Van Tine BA. Martín-Broto J, et al. Clin Cancer Res. 2020 Nov 15;26(22):5801-5808. doi: 10.1158/1078-0432.CCR-19-3335. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601077 Free PMC article. Review.
Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment.
Rogers LC, Kremer JC, Brashears CB, Lin Z, Hu Z, Bastos ACS, Baker A, Fettig N, Zhou D, Shoghi KI, Dehner CA, Chrisinger JSA, Bomalaski JS, Garcia BA, Oyama T, White EP, Van Tine BA. Rogers LC, et al. Clin Cancer Res. 2023 Aug 15;29(16):3189-3202. doi: 10.1158/1078-0432.CCR-22-2642. Clin Cancer Res. 2023. PMID: 37339179 Free PMC article.
Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102.
Brashears CB, Prudner BC, Rathore R, Caldwell KE, Dehner CA, Buchanan JL, Lange SES, Poulin N, Sehn JK, Roszik J, Spitzer D, Jones KB, O'Keefe R, Nielsen TO, Taylor EB, Held JM, Hawkins W, Van Tine BA. Brashears CB, et al. Clin Cancer Res. 2022 Aug 15;28(16):3573-3589. doi: 10.1158/1078-0432.CCR-22-0470. Clin Cancer Res. 2022. PMID: 35421237 Free PMC article.
Interim Analysis of the Phase II Study: Noninferiority Study of Doxorubicin with Upfront Dexrazoxane plus Olaratumab for Advanced or Metastatic Soft-Tissue Sarcoma.
Van Tine BA, Hirbe AC, Oppelt P, Frith AE, Rathore R, Mitchell JD, Wan F, Berry S, Landeau M, Heberton GA, Gorcsan J 3rd, Huntjens PR, Soyama Y, Vader JM, Alvarez-Cardona JA, Zhang KW, Lenihan DJ, Krone RJ. Van Tine BA, et al. Clin Cancer Res. 2021 Jul 15;27(14):3854-3860. doi: 10.1158/1078-0432.CCR-20-4621. Epub 2021 Mar 25. Clin Cancer Res. 2021. PMID: 33766818 Free PMC article. Clinical Trial.
11 results